Myasthenia gravis: a population-based epidemiological study.

Area of Science:

• Neurology
• Epidemiology

Background:

• Myasthenia Gravis (MG) impacts the neuromuscular junction.
• Epidemiological data indicate increasing incidence and prevalence rates globally.

Purpose of the Study:

• To ascertain the incidence and prevalence of Myasthenia Gravis within the Republic of Ireland.
• To analyze trends in MG diagnosis over recent decades.

Main Methods:

• Data compilation from multiple sources: neurologists, ophthalmologists, neuroimmunology labs, GPs, and the Myasthenia Gravis Association.
• Inclusion criteria focused on definite, probable, or possible autoimmune and congenital MG cases.
• Analysis of identified cases to determine prevalence and incidence rates.

Main Results:

• An overall prevalence rate of 15.38 per 100,000 individuals was calculated.
• A female predominance was observed (female:male ratio of 1.3:1).
• Incidence rates increased from 11.3 per year (2000-2009) to 18 per year (current decade).

Conclusions:

• The study confirms a rising prevalence and incidence of Myasthenia Gravis in Ireland.
• Enhanced diagnostic capabilities and increased clinical awareness likely contribute to higher reported diagnoses.
• Findings highlight the importance of ongoing epidemiological surveillance for Myasthenia Gravis.